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Abstract
Background  and  objectives:  Combined  spinal--epidural  (CSE)  has  become  an  increasingly  pop-
ular alternative  to  traditional  labour  epidural  due  to  its  rapid  onset  and  reliable  analgesia
provided.  This  was  a  prospective,  convenient  sampling  study  to  determine  the  effects  of  CSE
analgesia  on  labour  outcome.
Methods:  One  hundred  and  ten  healthy  primigravida  parturients  with  a  singleton  pregnancy  of
≥37 weeks  gestation  and  in  the  active  phase  of  labour  were  studied.  They  were  enrolled  to  the
CSE (n  =  55)  or  Non-CSE  (n  =  55)  group  based  on  whether  they  consented  to  CSE  analgesia.  Non-
CSE parturients  were  offered  other  methods  of  labour  analgesia.  The  duration  of  the  ﬁrst  and
second stage  of  labour,  rate  of  instrumental  vaginal  delivery  and  emergency  cesarean  section,
and Apgar  scores  were  compared.
Results:  The  mean  duration  of  the  ﬁrst  and  second  stage  of  labour  was  not  signiﬁcantly  different
between both  groups.  Instrumental  delivery  rates  between  the  groups  were  not  signiﬁcantly
different  (CSE  group,  11%  versus  Non-CSE  group,  16%).  The  slightly  higher  incidence  of  cesarean
section in  the  CSE  group  (16%  versus  15%  in  the  Non-CSE  group)  was  not  statistically  signiﬁcant.
Neonatal outcome  in  terms  of  Apgar  score  of  less  than  7  at  1  and  5  min  was  similar  in  both
groups.
Conclusion:  There  were  no  signiﬁcant  differences  in  the  duration  of  labour,  rate  of  instrumental
vaginal delivery  and  emergency  cesarean  section,  and  neonatal  outcome  in  parturients  who
received compared  to  those  who  did  not  receive  CSE  for  labour  analgesia.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  All  rights
reserved.∗ Corresponding author.
E-mail: nurlia@ppukm.ukm.edu.my (N. Yahya).
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0104-0014/© 2014 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. All rights reserved.
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Resultado  fetal;
Durac¸ão do  parto
Analgesia  combinada  raquiperidural  em  trabalho  de  parto:  seus  efeitos  sobre  o
desfecho  do  parto
Resumo
Justiﬁcativa  e  objetivos:  A  analgesia  combinada  raquiperidural  (RP)  tornou-se  uma  alternativa
cada vez  mais  popular  para  o  trabalho  de  parto  tradicional  devido  ao  seu  rápido  início  de
ac¸ão e  analgesia  conﬁável.  Este  foi  um  estudo  prospectivo  de  amostragem  conveniente  para
determinar  os  efeitos  da  RP  sobre  o  desfecho  do  parto.
Métodos:  Cento  e  dez  parturientes  primigestas  saudáveis,  com  gestac¸ão  única  de  ≥  37  semanas
de gestac¸ão  e  na  fase  ativa  do  trabalho  de  parto  foram  incluídas.  As  pacientes  foram  designadas
para os  grupos  RP  (n  =  55)  ou  não-RP  (n  =  55)  com  base  em  seus  consentimentos  para  a  analgesia
combinada RP.  As  parturientes  do  grupo  não-RP  receberam  outros  métodos  de  analgesia  para
o parto.  As  durac¸ões  do  primeiro  e  segundo  estágio  do  trabalho  de  parto,  as  taxas  de  parto
vaginal instrumental  e  cesariana  de  emergência  e  os  escores  de  Apgar  foram  comparados.
Resultados:  A  média  de  durac¸ão  do  primeiro  e  segundo  estágio  do  trabalho  de  parto  não  foi
signiﬁcativamente  diferente  entre  os  dois  grupos.  As  taxas  de  parto  instrumental  não  foram
signiﬁcativamente  diferentes  entre  os  grupos,  grupo  RP  (11%)  versus  grupo  não-RP  (16%).  A
incidência  ligeiramente  maior  de  cesariana  no  grupo  RP  (16%  versus  15%  no  grupo  não  RP)  não
foi estatisticamente  signiﬁcativa.  O  desfecho  neonatal  em  termos  de  índice  de  Apgar  inferior
a 7.
Conclusão:  Não  houve  diferenc¸as  signiﬁcativas  em  relac¸ão  à  durac¸ão  do  trabalho,  às  taxas  de
parto vaginal  instrumental  e  cesariana  de  emergência  e  ao  desfecho  neonatal  em  parturientes
que receberam  RP  para  analgesia  de  parto  em  comparac¸ão  com  aquelas  que  não  receberam.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
direitos reservados.
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abour  pain  is  one  of  the  most  distressing  types  of  pain  a
erson  may  have  to  endure.  The  American  College  of  Obste-
ricians  and  Gynaecologists  has  suggested  that:  ‘‘Labour
esults  in  severe  pain  for  many  women.  There  is  no  other
ircumstance  where  it  is  considered  acceptable  for  a person
o  experience  severe  pain,  amenable  to  safe  intervention,
hile  under  a  physician’s  care’’.1 More  women  nowadays  are
pting  for  pain  relief  methods  during  labour.  Epidural  anal-
esia  has  gained  increasing  popularity  worldwide  as  a  result
f  its  ability  to  provide  analgesia  which  is  more  superior  to
ther  methods  of  pain  relief.
Controversy  exists  however,  concerning  its  effect  on  the
ourse  and  outcome  of  labour.  As  a  result  of  this,  consid-
rable  research  has  been  performed  and  ﬁndings  have  led
o  changes  in  practice.  Epidural  analgesia  has  been  previ-
usly  implicated  in  prolonging  labour,  increasing  oxytocin
equirements,  as  well  as  increasing  instrumental  and  oper-
tive  delivery  rates.  However,  there  is  increasing  evidence
hich  refutes  some  of  these  claims.2
Combined  spinal--epidural  (CSE)  has  become  an  increas-
ngly  popular  alternative  to  the  traditional  epidural.
he  local  anaesthetic--opioid  combination  administered
ntrathecally  provides  rapid-onset,  potent  and  reliable  anal-
esia,  with  minimal  motor  blockade  during  the  ﬁrst  stage  of
abour,  enabling  maternal  mobility,  and  resulting  in  greater
aternal  satisfaction.3,4 A  recent  study  comparing  the  CSE
echnique  to  traditional  epidural  analgesia  showed  that,
lthough  both  techniques  were  excellent  analgesic  options,
w
t
cSE  provided  signiﬁcantly  faster  and  better  pain  relief  during
he  ﬁrst  stage  of  labour.5
Numerous  studies  comparing  epidural  and  CSE  or  epidu-
al  and  non-epidural  analgesia  have  shown  variable  results,
ut  none  have  compared  CSE  with  other  methods  of  labour
nalgesia.6--8 In  the  Cochrane  database  of  systematic  reviews
n  2011  comparing  epidural  versus  non-epidural  or  no  anal-
esia  in  labour,  CSE  was  included  together  with  epidural
nalgesia  and  not  as  a  separate  entity.  In  view  of  the  above,
e  decided  to  look  at  the  effect  CSE  had  on  labour  outcome
ompared  with  alternative  methods  of  labour  analgesia.  Our
ndpoints  were  duration  of  the  active  phase  of  the  ﬁrst  and
econd  stages  of  labour,  rate  of  instrumental  vaginal  delivery
nd  emergency  cesarean  section,  and  neonatal  outcome.
ethods
his  prospective,  convenient  sampling  study  was  conducted
fter  obtaining  institutional  ethics  approval.  A  total  of  110
arturients  of  American  Society  of  Anesthesiology  (ASA)  I
hysical  status  was  enrolled  in  this  study  after  informed
onsent  was  obtained.  The  parturients  were  primigravid,
ged  between  20  and  40  years  with  a  singleton  pregnancy
f  ≥37  weeks  gestation  and  in  the  active  phase  of  labour
ith  cervical  dilatation  of  3--4  cm.  Any  parturient  with  preg-
ancy  related  illness  or  contraindications  to  CSE  analgesia
as  excluded  from  this  study.
The  parturients  were  ﬁrst  examined  by  the  obstetric
eam  in  the  ward.  A  detailed  obstetric  history  was  taken  and
ephalic  foetal  presentation  conﬁrmed  by  a  scan.  When  the
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CEffects  of  CSE  on  outcome  of  labour  
parturients  were  conﬁrmed  by  the  obstetric  team  to  be  in
the  active  phase  of  labour  (cervical  dilatation  of  3--4  cm  with
regular  contractions),  they  were  transferred  to  the  labour
room.  Those  who  consented  to  CSE  analgesia  were  enrolled
into  the  CSE  group,  whereas  parturients  who  declined  CSE
analgesia  were  offered  other  forms  of  analgesia  and  enrolled
into  the  Non-CSE  group.  Parturients  in  the  Non-CSE  group
were  offered  either  entonox  (N2O/O2;  50%/50%)  or  intramus-
cular  (IM)  pethidine  50  mg  with  IM  promethazine  (Phenergan)
12.5  mg.  The  parturient’s  blood  pressure  and  pulse  rate  were
monitored  at  hourly  intervals.  Foetal  heart  rate  and  the  fre-
quency  and  duration  of  uterine  contractions  were  assessed
with  continuous  cardiotocographic  monitoring.
In  the  CSE  group,  infusion  of  lactated  Ringer’s  solution
was  commenced  and  the  parturients  were  placed  in  the
sitting  position.  The  procedure  was  performed  under  asep-
tic  precautions  at  L3--L4  or  L4--L5  using  a  pre-packed  set
containing  an  18-gauge  epidural  needle,  20-gauge  epidural
catheter  and  27-gauge  spinal  needle  (BD  DurasafeTM Plus).
The  epidural  space  was  identiﬁed  using  the  loss  of  resis-
tance  to  saline  technique,  after  which  the  spinal  needle
was  inserted  through  the  epidural  needle.  Upon  visualiza-
tion  of  backﬂow  of  cerebrospinal  ﬂuid,  an  intrathecal  dose
of  0.5  mL  of  0.2%  ropivacaine  with  0.5  mL  of  fentanyl  (25  g)
was  administered.  The  epidural  catheter  was  then  inserted
3--5  cm  into  the  epidural  space  and  secured.  The  parturient
was  then  positioned  supine  with  left  uterine  displacement
and  the  head  end  of  the  bed  elevated  to  20--30◦. The  level
of  sensory  blockade  was  checked  to  ensure  the  sensory  level
was  ≥T10,  after  which  an  epidural  infusion  of  0.0625%  ropi-
vacaine  with  fentanyl  2  g/mL  was  started  at  8  mL/h.  The
parturients’  hemodynamic  parameters  were  monitored  at
5  min  intervals  during  and  after  the  procedure  for  the  ﬁrst
15  min,  then  every  15  min  for  the  ﬁrst  hour,  then  half-hourly
after  that.  Hypotension,  deﬁned  as  a  20%  reduction  in  sys-
tolic  blood  pressure  from  baseline,  was  treated  by  turning
the  parturient  to  the  left  lateral  position  and  administering
maternal  oxygen,  intravenous  ﬂuid  infusion,  or  vasopres-
sor  (ephedrine  6  mg  or  phenylephrine  50  g  per  bolus)  as
indicated.
Throughout  labour,  sensory  level,  motor  block  and  pain
score  were  assessed  at  hourly  intervals.  The  degree  of  motor
block  was  assessed  using  the  Modiﬁed  Bromage  Score  (MBS)
where  1,  complete  block,  unable  to  move  feet  or  knee;  2,
almost  complete  block,  able  to  move  feet  only;  3,  partial
block,  just  able  to  move  the  knees;  4,  detectable  weakness
of  hip  ﬂexion  while  supine;  5,  no  detectable  weakness  of  hip
ﬂexion  while  supine.  Parturients  with  MBS  ≤2  and/or  sensory
level  ≥T6  was  regarded  as  having  an  excessively  dense  or
high  epidural  block  respectively,  and  managed  accordingly.
Pain  was  assessed  using  the  Numeric  Rating  Scale  (NRS)
with  scores  ranging  from  0,  indicating  no  pain  to  10,  being
the  worst  pain  imaginable.  Breakthrough  pain  was  managed
by  administering  additional  epidural  bolus  doses  and/or
increasing  the  epidural  infusion  rate,  depending  on  the  NRS
score.  For  parturients  with  pain  scores  of  3--5,  the  epidu-
ral  infusion  rate  was  increased  incrementally  to  a  maximum
of  12  mL/h.  Those  with  pain  scores  ≥6  were  given  2--3  mL
bolus  doses  of  epidural  lignocaine  2%  to  a  maximum  of  8  mL.
The  epidural  was  assumed  to  be  ineffective  if  signiﬁcant
pain  (NRS  score  >5)  persisted  despite  the  maximum  top  up
dose.  These  parturients  were  offered  to  have  the  epidural
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e-sited.  If  they  were  not  keen  to  do  so,  an  alternative
eans  of  analgesia  would  be  administered.  Parturients  who
equired  re-siting  of  the  epidural  or  an  alternative  means  of
nalgesia  were  excluded  from  this  study.  The  epidural  infu-
ion  was  continued  until  delivery  of  the  baby  and  ceased
nly  after  the  episiotomy  wound  was  sutured.
Obstetric  management  was  similar  in  both  groups.
mniotomy  was  performed  if  the  foetal  membranes  were
ntact.  Pelvic  examination  to  evaluate  the  progress  of  labour
as  performed  at  regular  intervals  as  per  labour  manage-
ent  protocol.  Oxytocin  augmentation  was  prescribed  as
ecessary  to  achieve  a  cervical  dilation  rate  of  ≥1  cm/h.
he  decision  to  proceed  to  vaginal  instrumental  or  oper-
tive  delivery  was  made  according  to  maternal  or  foetal
ndications.
Data  collected  included  duration  of  the  ﬁrst  and  second
tages  of  labour,  oxytocin  augmentation,  labour  outcome
spontaneous  vaginal  delivery,  instrumental  vaginal  delivery
r  cesarean  section)  as  well  as  1-  and  5-min  Apgar  scores.
he  indication  for  emergency  lower  segment  cesarean  sec-
ion  (EMLSCS)  was  also  recorded.  Foetal  outcome  was
ssessed  based  on  previous  studies  where  scores  less  than
 were  considered  as  poor  Apgar  scores.4,9 In  addition,  any
ncidence  of  post-partum  haemorrhage  was  recorded  and
or  the  patients  in  the  CSE  group,  any  side-effects  experi-
nced  (e.g.  nausea,  vomiting,  pruritus,  post-dural  puncture
eadache)  were  documented  and  managed  accordingly.  For
atients  in  the  Non-CSE  group,  reasons  for  declining  CSE
nalgesia  were  also  documented.
tatistical analysis
ample  size  was  calculated  using  the  formula  by  Snedecor
nd  Cochran  (1989)  for  continuous  variables.  The  constant
alue  of  10.51  was  based  on  an  ˛-value  of  0.05  and  a  power
f  90%.  Using  this  formula,  a  sample  size  of  45  patients  for
ach  group  was  obtained.  Considering  a  dropout  rate  of  20%,
5  patients  were  required  on  each  arm.  SPSS  (version  20;  IBM
PSS  Inc.)  was  used  for  statistical  analysis.  Data  analysis  was
one  using  the  independent  t-test  for  parametric  data  and
he  chi-square  test  for  non-parametric  data.  A  p-value  of
ess  than  0.05  was  considered  as  statistically  signiﬁcant.
esults
 total  of  110  parturients  were  enrolled  in  this  study  with
5  parturients  in  each  group.  Table  1  shows  parturient
haracteristics  in  both  groups.  There  were  no  signiﬁcant  dif-
erences  in  terms  of  age,  weight,  height,  body  mass  index
BMI)  and  gestational  age  of  the  parturients  in  both  groups.
There  was  no  signiﬁcant  difference  in  the  duration  of  the
rst  and  second  stages  of  labour  between  both  groups  as
hown  in  Table  2. The  percentage  of  patients  who  received
xytocin  was  71%  and  65%  in  the  CSE  and  Non-CSE  groups
espectively,  and  this  was  not  signiﬁcantly  different.  A  total
f  46  patients  in  the  CSE  group  and  47  patients  in  the  Non-
SE  group  had  delivered  vaginally.  The  rates  of  spontaneous
nd  instrumental  vaginal  delivery  were  not  statistically  dif-
erent  between  the  groups.  Vacuum  delivery  was  the  most
ommon  mode  of  instrumental  assisted  delivery.  The  rate  of
MLSCS  did  not  signiﬁcantly  differ  between  the  two  groups.
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Table  1  Parturient  characteristics  (values  expressed  as  mean  ±  standard  deviation).
CSE  group  (n  =  55)  Non-CSE  group  (n  =  55)  p
Age  28.8  ±  3.6  28.6  ±  3.8  0.755
Weight (kg)  67.2  ±  13.6  66.2  ±  14.4  0.717
Height (m)  1.6  ±  0.1  1.6  ±  0.1  0.642
BMI (kg/m2)  26.7  ±  5.0  26.6  ±  5.3  0.857
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he  main  indication  for  EMLSCS  was  foetal  distress,  account-
ng  for  14.5%  and  10.9%  of  the  cases  in  the  CSE  and  Non-CSE
roup  respectively.  EMLSCS  was  indicated  for  poor  progress
n  the  remaining  cases  of  both  groups.
At  1  min,  three  and  two  neonates  in  the  CSE  and  Non-
SE  groups  respectively  had  Apgar  scores  of  less  than  7,  but
he  difference  was  not  statistically  signiﬁcant.  None  of  the
eonates  had  an  Apgar  score  of  less  than  7  at  5  min.
Pruritus  was  by  far  the  most  common  complication  in  the
SE  group.  This  was  present  in  24  parturients  (44%)  but  was
hort-lived  and  did  not  require  intervention.  Two  parturi-
nts  (3.6%)  in  the  CSE  group  complained  of  nausea  without
omiting.  There  were  no  other  CSE  related  complications
uch  as  post-dural  puncture  headache  and  hypotension,  or
ther  complications  such  as  post-partum  haemorrhage.  Par-
urients  who  declined  CSE  analgesia  gave  reasons  of  fear  of
ackache,  numbness  or  the  inability  to  bear  down  during  the
econd  stage  of  labour.
iscussion
he  effect  of  neuraxial  analgesia  in  labour  and  obstetric  out-
omes  has  been  studied  extensively  over  the  years.  Among
he  endpoints  studied  were  duration  of  ﬁrst  and  second
tages  of  labour,  oxytocin  augmentation,  rate  of  instru-
ental  and  cesarean  deliveries,  maternal  satisfaction  and
eonatal  outcome.10--13
The  present  study  showed  that  the  duration  of  ﬁrst  stage
f  labour  was  not  prolonged  in  parturients  who  received  CSE
nalgesia.  The  slight  increase  in  the  mean  duration  of  the
ctive  phase  labour  in  the  CSE  group  (352.3  min  as  com-
ared  to  347.2  min  in  the  Non  CSE  group)  did  not  reach
e
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Table  2  Labour  characteristics  (values  expressed  mean  ±  SD,  or  as
CSE  group  (n  =  55)
Duration  of  ﬁrst  stage  (h)  5.5  ±  0.9  
Duration of  second  stage  (min)  22.3  ±  8.6  
Oxytocin augmentation  39  (71%)  
Mode of  delivery
Spontaneous  vaginal  delivery  41  (74.6)  
Instrumental  vaginal  delivery
Forceps  1  (1.8)  
Vacuum 4  (7.2)  
EMLSCS 
Foetal distress  8  (14.5)  
Poor progress  1  (0.02)  38.7  ±  0.7  0.427
tatistical  signiﬁcance.  Previous  studies  comparing  epidu-
al  analgesia  with  systemic  opioids  have  shown  inconsistent
esults.  Epidural  analgesia  was  either  implicated  in  prolong-
ng  or  showed  no  effect  on  the  ﬁrst  stage  of  labour.13--17
nterestingly,  Tsen  et  al.  demonstrated  that  CSE  was  associ-
ted  with  an  increased  cervical  dilatation  rate  in  nulliparous
atients.18 The  authors  postulated  that  the  spinal  anal-
esia  of  a  CSE  technique  allowed,  at  least  initially  and
otentially  during  the  course  of  labour,  for  a  reduction
n  local  anaesthetic  dosage  when  compared  with  conven-
ional  epidural  analgesia.  Another  postulate  was  that  painful
abour  resulted  in  an  increase  in  maternal  adrenaline  level,
hich  may  be  tocolytic  in  itself.  There  is  evidence  to  demon-
trate  that  epidural  analgesia  may  accelerate  labour  as
he  provision  of  effective  analgesia  reduces  maternal  cat-
cholamines,  and  hence  minimizing  its  inhibitory  effect  on
terine  contractility.19 The  use  of  CSE  analgesia  with  its
apid  onset  and  similar  analgesic  efﬁcacy  would  thus  be
xpected  to  have  a  similar  effect  on  the  duration  of  labour.
Epidural  analgesia  has  been  thought  to  prolong  the  sec-
nd  stage  of  labour  by  removing  the  parturient’s  involuntary
earing  down  reﬂex,  or  by  interfering  with  motor  function.15
oor  maternal  effort  at  expulsion  may  cause  foetal  mal-
osition  during  descent,  which  may  lead  to  intervention
n  the  form  of  instrumental  delivery  or  cesarean  section.
owever,  in  modern-day  practice  when  dilute  local  anaes-
hetic  solutions  are  used  to  provide  epidural  analgesia,  the
otor  blockade  and  hence  weakness  of  pelvic  ﬂoor  muscle  is
ither  minimal  or  absent.  This  was  conﬁrmed  by  a  recently
ublished  meta-analysis  on  the  effect  of  low  concentra-
ions  versus  high  concentrations  of  local  anaesthetics  for
abour  analgesia  on  obstetric  and  anaesthetic  outcomes.20
 numbers  with  percentage  in  parentheses  where  appropriate).
 Non-CSE  group  (n  =  55)  p
5.4  ±  1.2  0.718
23.2  ±  11.5  0.675
36  (65%)  0.341
40  (72.7)  0.917
1  (1.8)  1.000
6  (10.9)  0.527
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REffects  of  CSE  on  outcome  of  labour  
The  authors  found  that  low  concentrations  were  associated
with  a  reduction  in  the  incidence  of  assisted  vaginal  delivery
and  a  shorter  second  stage  of  labour.  We  used  an  epidural
infusion  with  a  low  concentration  of  0.0625%  ropivacaine
with  fentanyl  2 g/mL  in  our  study  as  per  institutional  pro-
tocol.  It  is  of  no  surprise  that  our  study  found  no  signiﬁcant
difference  between  the  CSE  and  Non-CSE  group,  in  the  dura-
tion  of  the  second  stage  of  labour.  This  is  similar  to  other
randomized  controlled  trials  which  compared  CSE  with  con-
ventional  epidural  analgesia.21,22
The  instrumental  delivery  rate  is  yet  another  impor-
tant  outcome  measure,  as  the  procedure  increases  the  risk
of  maternal  perineal  trauma,  and  adverse  neonatal  out-
comes  in  cases  of  difﬁcult  delivery.13 The  2011  Cochrane
review  on  epidural  versus  non-epidural  or  no  analgesia  in
labour  showed  that  epidural  analgesia  was  associated  with
an  increased  risk  of  assisted  vaginal  birth.8 However,  we
found  that  the  incidence  of  instrumental  delivery  was  not
signiﬁcantly  different  (CSE,  9.0%  versus  Non-CSE,  12.7%).
This  was  in  contrast  to  earlier  studies  which  reported
higher  rates  of  instrumental  delivery  in  epidural  compared
to  parenteral  opioids  or  entonox.9,12 Studies  which  com-
pared  CSE  with  epidural  have  reported  no  differences  in
the  mode  of  delivery.21,22 It  must  be  noted  that  results  are
often  affected  by  multiple  confounding  factors,  such  as  the
neuraxial  analgesic  technique,  method  of  epidural  analge-
sia  maintenance,  local  anaesthetic  concentration,  degree
of  analgesia  during  second  stage  of  labour  and  obstetric
factors.13
Considerable  data  support  the  notion  that  neuraxial
labour  analgesia  does  not  increase  the  risk  of  cesarean
delivery  compared  with  systemic  analgesia.13 In  this  study,
we  found  no  signiﬁcant  increase  in  the  rates  of  cesarean
delivery  in  parturients  who  received  CSE  analgesia.  The
Cochrane  review  on  epidural  versus  non-epidural  or  no  anal-
gesia  in  labour  showed  that  there  was  no  evidence  of  a
signiﬁcant  difference  in  the  risk  of  cesarean  section  overall
even  though  there  was  an  increased  risk  of  cesarean  sec-
tion  for  foetal  distress.8 Similarly,  Halpern  et  al.  reported
that  the  risk  of  cesarean  delivery  was  no  different  between
women  who  received  systemic  opioids  versus  neuraxial
analgesia.17 It  must  also  be  emphasised  that  many  fac-
tors  other  than  labour  progress  may  contribute  to  cesarean
delivery,  such  as  cephalo-pelvic  disproportion,  a  macrosomic
baby,  maternal  infection  and  parity.13 The  results  of  these
studies,  including  our  own,  imply  that  neuraxial  analgesia
per  se  is  unlikely  to  affect  the  chances  of  a  normal  deliv-
ery.
Neonatal  outcome  assessed  by  Apgar  scores,  was  similar
in  both  groups.  All  ﬁve  neonates  in  both  groups  with  Apgar
scores  less  than  7  at  1  min  recovered  at  5  min.  This  is  in
accordance  with  other  studies  which  showed  no  difference
in  Apgar  scores  or  cord  pH  in  patients  receiving  epidural  or
CSE  analgesia.6,9,12,23
The  most  common  side  effect  in  parturients  who  received
CSE  analgesia  was  pruritus,  which  occurred  in  44%  of  our
parturients.  This  was  transient  and  tolerable,  requiring  no
treatment.  Feedback  from  patients  have  revealed  pruritus
as  the  most  common  side  effect  of  intrathecal  opioids.24 Miro
et  al.  in  their  study  concluded  that  although  CSE  analgesia
was  more  commonly  associated  with  pruritus  and  back  pain,
nevertheless  it  afforded  analgesia  of  superior  quality.23263
There  were  some  limitations  in  this  study.  Blinding
f  clinicians  was  difﬁcult  since  parturients  were  easily
ifferentiated  between  the  CSE  and  Non-CSE  group.  Even
hough  this  may  lower  the  threshold  for  instrumental  deliv-
ry  in  the  CSE  group,  this  was  reduced  by  strict  adherence  to
nstitutional  obstetric  management  protocols.  Secondly,  as
his  study  included  only  ASA  I  parturients,  its  results  cannot
e  extrapolated  to  patients  with  signiﬁcant  medical  or  preg-
ancy  related  illness.  These  co-morbidities  may  inﬂuence
bstetric  management,  thus  affecting  the  rate  of  instru-
ental  or  cesarean  delivery  and  possibly  neonatal  outcome.
hirdly,  the  subjective  assessment  of  cervical  dilatation  may
ary  among  doctors  of  differing  experience,  thus  affect-
ng  the  actual  assessment  of  duration  of  labour.  Oxytocin
ugmentation  poses  another  confounding  factor  to  labour
uration.  As  it  was  part  of  our  institutional  obstetric  pro-
ocol,  most  of  our  parturients  received  oxytocin  but  we  did
ot  keep  record  whether  it  was  administered  before  or  after
ommencement  of  labour  analgesia.  Oxytocin  per  se  may
ccelerate  labour  progression.  On  the  other  hand,  the  provi-
ion  of  effective  labour  analgesia  could  be  partly  responsible
or  hastening  the  process  of  labour.  However  there  may  have
een  some  parturients  who  despite  being  given  labour  anal-
esia,  had  no  alleviation  of  pain.  Suboptimal  pain  relief  may
etard  labour  progression  thus  prompting  administration  of
xytocin.  Finally,  with  regards  neonatal  outcome,  we  only
ompared  the  Apgar  scores  between  the  two  groups.  Other
ndices  for  neonatal  wellbeing,  such  as  umbilical  cord  pH,
he  need  for  naloxone,  mechanical  ventilation  or  admission
o  Neonatal  Intensive  Care  Unit,  were  not  investigated  in
ur  study.
Overall,  this  study  supports  other  studies  which  found
hat  CSE  analgesia  did  not  adversely  affect  the  outcome  of
abour.17,18 Labouring  women  can  be  reassured  that,  in  addi-
ion  to  obtaining  superior  analgesia  with  CSE,  they  would  be
ble  to  experience  a  safe  and  normal  vaginal  delivery.  In
onclusion,  the  present  study  demonstrated  that  there  was
o  signiﬁcant  difference  in  the  duration  of  labour,  rate  of
nstrumental  vaginal  delivery  and  emergency  cesarean  sec-
ion,  and  neonatal  outcome  in  parturients  who  received,
ompared  to  those  who  did  not  receive  CSE  for  labour  anal-
esia.
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